SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (SNDX) Q2 2021 Earnings Conference Call August 09, 2021, 16:30 ET Company Participants Melissa Forst - Argot Partners Briggs Morrison - CEO & Director Daphne Karydas - CFO Michael Meyers - Chief Medical Officer & SVP Conference Call Participants Philip Nadeau - Cowen and Company Joel Beatty - Robert W. Baird & Co. Peter Lawson - Barclays Bank Justin Walsh - B. Riley Securities David Lebowitz - Morgan Stanley Presentation Operator Thank you for standing by, and welcome to the Syndax Second Quarter 2021 Financial Results Conference Call. [Operator Instructions]. As a reminder, today's conference call is being recorded. I would now turn the conference over to your host, Melissa Forst with Argot Partners. You may begin. Melissa Forst Thank you, Valerie. Welcome and thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax's second quarter
For further details see:
Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call Transcript